MODULATION OF DOXORUBICIN - INDUCED DNA LESIONS BY VERAPAMIL, DMDP AND DIPYRIDAMOLE IN RESISTANT P388-CELL LINES

被引：0
|
作者：
YIN, MB [1 ]
BANKUSLI, I [1 ]
FRANK, C [1 ]
RUSTUM, YM [1 ]
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GRACE CANC DRUG CTR,ELM & CARLTON ST,BUFFALO,NY 14263
来源：
ANTICANCER RESEARCH | 1990年 / 10卷 / 2A期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：327 / 332
页数：6
相关论文
共 50 条
  • [21] CELLULAR PHARMACOLOGY OF DOXORUBICIN OR ITS METABOLITE DOXORUBICINOL COMBINED WITH VERAPAMIL IN SENSITIVE AND RESISTANT PANCREATIC-CANCER CELL-LINES
    CHANG, BK
    BRENNER, DE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 394 - 394
  • [22] Modulation of mdr-1 Expression and Activity by Verapamil and Resveratrol Potentiates the Cytotoxicity of Docetaxel and Doxorubicin in Solid Tumor Cell Lines
    El-Moselhy, Mohamed Ahmed Mohamed
    El-Sherbiny, Gamal Ahmed
    Abd Abdel-Latif, Hekma Abdel-Tawab
    Al-Abd, Ahmed Mohamed
    Nofal, Salwa Mohamed
    El-Eraky, Wafaa Ibraheem
    FASEB JOURNAL, 2012, 26
  • [23] ANTHRACYCLINE PHOTOAFFINITY-LABELING OF AN 18 KDALT PROTEIN IN P388 SENSITIVE AND RESISTANT CELL-LINES
    AVERBUCH, SD
    GLOVER, CJ
    SEWELL, JL
    FELSTED, RL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 223 - 223
  • [24] ENHANCEMENT OF VINCRISTINE-INDUCED AND ADRIAMYCIN-INDUCED CYTO-TOXICITY BY VERAPAMIL IN P388 LEUKEMIA AND ITS SUBLINES RESISTANT TO VINCRISTINE AND ADRIAMYCIN
    TSURUO, T
    IIDA, H
    YAMASHIRO, M
    TSUKAGOSHI, S
    SAKURAI, Y
    BIOCHEMICAL PHARMACOLOGY, 1982, 31 (19) : 3138 - 3140
  • [25] VERAPAMIL DECREASES P-GLYCOPROTEIN EXPRESSION IN MULTIDRUG-RESISTANT HUMAN LEUKEMIC-CELL LINES
    MULLER, C
    BAILLY, JD
    GOUBIN, F
    LAREDO, J
    JAFFREZOU, JP
    BORDIER, C
    LAURENT, G
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (05) : 749 - 754
  • [26] Evidence of difference between cytotoxicity, cell cycle and morphonuclear effects of polyamines on sensitive and multidrug resistant P388 cell lines
    Berlaimont, V
    Pauwels, O
    Dubois, J
    Hanocq, M
    ANTICANCER RESEARCH, 1997, 17 (3C) : 2057 - 2064
  • [27] IDARUBICIN IS ACTIVE ON MDR CELLS - EVALUATION OF DNA-SYNTHESIS INHIBITION ON P388 CELL-LINES
    PETRINI, M
    MATTII, L
    VALENTINI, P
    SABBATINI, ARM
    GRASSI, B
    GRANDI, M
    ANNALS OF HEMATOLOGY, 1993, 67 (05) : 227 - 230
  • [28] DIFFERENTIAL MODULATION OF DOXORUBICIN TOXICITY TO MULTIDRUG AND INTRINSICALLY DRUG-RESISTANT CELL-LINES BY ANTIESTROGENS AND THEIR MAJOR METABOLITES
    KIRK, J
    HOULBROOK, S
    STUART, NSA
    STRATFORD, IJ
    HARRIS, AL
    CARMICHAEL, J
    BRITISH JOURNAL OF CANCER, 1993, 67 (06) : 1189 - 1195
  • [29] P-GLYCOPROTEIN EXPRESSION AND MODULATION OF CELL-MEMBRANE MORPHOLOGY IN ADRIAMYCIN-RESISTANT P388 LEUKEMIA-CELLS
    RADEL, S
    FREDERICKS, W
    MAYHEW, E
    BAKER, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) : 241 - 246
  • [30] COMPARISON OF THE EFFICACY OF A PHENOTHIAZINE AND A BISQUINALDINIUM CALMODULIN ANTAGONIST AGAINST MULTIDRUG-RESISTANT P388 CELL-LINES
    HAIT, WN
    PIERSON, NR
    CANCER RESEARCH, 1990, 50 (04) : 1165 - 1169
12345